Partha S. Mukherjee

Partha S. Mukherjee is an accomplished professional in the field of pharmaceutical analysis and analytical development. Currently serving as Sr. Director/Head CMC Analytical Development at Amicus Therapeutics since 2022, Mukherjee has previously held significant roles, including Director of Chemistry, Manufacturing, and Controls at Certara and Director of Analytical Development at Bristol-Myers Squibb/Celgene. Notable contributions include leading R&D and GMP Stability programs for small molecules and managing a global R&D stability team for GSK. Mukherjee's extensive experience spans various organizations such as Novartis, Endo Pharmaceuticals, AstraZeneca, Pfizer, and Battelle, complemented by a Ph.D. in Pharmaceutical Analysis from Virginia Commonwealth University.